Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Clinical trial NCT00540423 · COMPLETED

Trial details

NCT number: NCT00540423
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Idiopathic Thrombocytopenic Purpura Purpura, Thrombocytopenic, Idiopathic

Start date: 2007-09-01
Primary completion: 2008-12-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.